Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 12
Submit an article Journal homepage
327
Views
16
CrossRef citations to date
0
Altmetric
Letters to the Editor

The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes

Aziz NazhaLeukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH, USA
,
David P. SeastoneLeukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH, USA
,
Michael KengLeukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH, USA
,
Sean HobsonLeukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH, USA
,
Matt KalaycioLeukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH, USA
,
Jaroslaw P. MaciejewskiDepartment of Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA
&
Mikkael A. SekeresLeukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH, USACorrespondence[email protected]
 show all
Pages 3437-3439 | Received 08 Mar 2015, Accepted 10 Apr 2015, Published online: 19 Jun 2015

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Amy E. DeZern & William Brian Dalton. (2022) How low risk are low risk myelodysplastic syndromes?. Expert Review of Hematology 15:1, pages 15-24.
Read now
Sagar S. Patel, Mikkael A. Sekeres & Aziz Nazha. (2017) Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure. Leukemia & Lymphoma 58:11, pages 2532-2539.
Read now

Articles from other publishers (14)

Amy E. DeZern. (2021) Lower risk but high risk. Hematology 2021:1, pages 428-434.
Crossref
A. Kuendgen, M. Nomdedeu, H. Tuechler, G. Garcia-Manero, R. S. Komrokji, M. A. Sekeres, M. G. Della Porta, M. Cazzola, A. E. DeZern, G. J. Roboz, D. P. Steensma, A. A. Van de Loosdrecht, R. F. Schlenk, J. Grau, X. Calvo, S. Blum, A. Pereira, P. Valent, D. Costa, A. Giagounidis, B. Xicoy, H. Döhner, U. Platzbecker, C. Pedro, M. Lübbert, I. Oiartzabal, M. Díez-Campelo, M. T. Cedena, S. Machherndl-Spandl, M. López-Pavía, C. D. Baldus, M. Martinez-de-Sola, R. Stauder, B. Merchan, A. List, C. Ganster, T. Schroeder, M. T. Voso, M. Pfeilstöcker, H. Sill, B. Hildebrandt, J. Esteve, B. Nomdedeu, F. Cobo, R. Haas, F. Sole, U. Germing, P. L. Greenberg, D. Haase & G. Sanz. (2020) Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS. Leukemia 35:3, pages 835-849.
Crossref
А.С. Трубкина, И.А. Искров & И.Ю. Лендина. (2020) Prognostic Risk Factors in Myelodysplastic Syndromes in Adults. Гематология. Трансфузиология. Восточная Европа:3, pages 347-356.
Crossref
Jacob Shreve & Aziz Nazha. (2020) Novel Prognostic Models for Myelodysplastic Syndromes. Hematology/Oncology Clinics of North America 34:2, pages 369-378.
Crossref
Jan Philipp Bewersdorf & Amer M. Zeidan. 2020. Diagnosis and Management of Myelodysplastic Syndromes. Diagnosis and Management of Myelodysplastic Syndromes 109 127 .
Amer M. Zeidan, Rory M. Shallis, Rong Wang, Amy Davidoff & Xiaomei Ma. (2019) Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Reviews 34, pages 1-15.
Crossref
Aziz Nazha. (2018) The MDS genomics-prognosis symbiosis. Hematology 2018:1, pages 270-276.
Crossref
Aziz Nazha & Mrinal M. Patnaik. (2018) Making Sense of Prognostic Models in Chronic Myelomonocytic Leukemia. Current Hematologic Malignancy Reports 13:5, pages 341-347.
Crossref
Daniel Moreno Berggren, Yasin Folkvaljon, Marie Engvall, Johan Sundberg, Mats Lambe, Petar Antunovic, Hege Garelius, Fryderyk Lorenz, Lars Nilsson, Bengt Rasmussen, Sören Lehmann, Eva Hellström‐Lindberg, Martin Jädersten & Elisabeth Ejerblad. (2018) Prognostic scoring systems for myelodysplastic syndromes ( MDS ) in a population‐based setting: a report from the Swedish MDS register . British Journal of Haematology 181:5, pages 614-627.
Crossref
Wei ZhouShilin XuYi YingRuiqing ZhouXiaowei Chen. (2017) Resveratrol Suppresses Growth and Migration of Myelodysplastic Cells by Inhibiting the Expression of Elevated Cyclin D1 ( CCND1 ) . DNA and Cell Biology 36:11, pages 966-975.
Crossref
Aziz Nazha & Rafael Bejar. (2017) Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS. Current Hematologic Malignancy Reports 12:5, pages 461-467.
Crossref
Abdallah Abou Zahr, Ami M. Kavi, Sudipto Mukherjee & Amer M Zeidan. (2017) Therapy-related myelodysplastic syndromes, or are they?. Blood Reviews 31:3, pages 119-128.
Crossref
Aziz NazhaMikkael A. Sekeres. (2017) Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations. Annual Review of Medicine 68:1, pages 127-137.
Crossref
Aziz Nazha & Mikkael A. Sekeres. (2016) Improving Prognostic Modeling in Myelodysplastic Syndromes. Current Hematologic Malignancy Reports 11:6, pages 395-401.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.